Financhill
Back

Jones Lang LaSalle Vs. Novo Nordisk AS Industry Stock Comparison

Buy
55

JLL
Jones Lang LaSalle

Last Price:
$252.85
Seasonality Move:
10.07%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Buy
55
Jones Lang LaSalle (JLL) is a Buy

Is Jones Lang LaSalle a Buy, Sell or Hold?

  • The current Jones Lang LaSalle [JLL] share price is $252.74. The Score for JLL is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • JLL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JLL Stock Price Chart

What is Jones Lang LaSalle's stock price today?

  • The Jones Lang LaSalle share price today is $252.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JLL is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

JLL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.27 Sell
Relative Strength Index (14 RSI): 38.28 Sell
Chaikin Money Flow: 710445 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (259.07 - 279.53) Sell
Bollinger Bands (100): (248.38 - 272.86) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

JLL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 264.46 Sell
20-day SMA: 271.76 Sell
50-day SMA: 268.52 Sell
200-day SMA: 230.14 Buy
8-day EMA: 261.14 Sell
20-day EMA: 266.82 Sell
50-day EMA: 266.22 Sell
200-day EMA: 236.17 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Jones Lang LaSalle Earnings Growth & JLL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.32 per share, and an increase next year of $2.96 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

Jones Lang LaSalle Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):